Former Chief Financial Officer (6) · UroGen Pharma Ltd. (URGN)

Molly Henderson

A named executive officer of UroGen Pharma in every fiscal year CompBrief holds from FY2020 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$904,759

Salary $434,113Stock awards $44,140

FY2020: $1,362,230

4th of 4 named executive officers at UroGen Pharma by FY2021 total.

4 named officers on file for UroGen Pharma, FY2021

Molly Henderson’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 2 equity grants, each cited to its filing
  • URGN’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how UroGen Pharma’s whole pay program stands against its peers

  • UroGen Pharma’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on URGN→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed May 2, 2022 (DEF 14A).

Free

Get Molly Henderson’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Molly Henderson compensation by year

UroGen Pharma Summary Compensation Table · all 2 fiscal years held
In US dollars, as UroGen Pharma reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021
Salary$94,269$434,113
Bonus$100,000$0
Stock awards$294,900$44,140
Option awards$787,994$267,023
Non-equity incentive$69,875$99,700
Pension and deferred compensation$0$0
All other$15,192$59,782
Total$1,362,230$904,759

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: UroGen Pharma Ltd. DEF 14A filed May 2, 2022, accession 0001437749-22-010483, and prior-year filings. Open the filing on EDGAR.

How this page was built: the UroGen Pharma Ltd. filed document, accession 0001437749-22-010483. Every figure is read from that document and cited to the page and table it appears in. Filed May 2, 2022.

$1.4M
$905K
FY20
FY21
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
RSU15,000$142,650—
RSU2,000$19,020—
Option60,000—$19.66
Option6,000—$22.07

Per the Outstanding Equity Awards at Fiscal Year-End table in UroGen Pharma Ltd.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

UroGen Pharma’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Elizabeth BarrettChief Executive Officer$4,365,748
Jason SmithGeneral Counsel and Chief Compliance Officer$1,058,671
Mark SchoenbergChief Medical Officer$1,024,138
Molly Henderson · this pageFormer Chief Financial Officer (6)$904,759

The full UroGen Pharma compensation record

free company brief

This page is one person within UroGen Pharma's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the UroGen Pharma proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are UroGen Pharma's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Molly Henderson's compensation dossier · One-time report. No refunds.